共 39 条
[23]
Mathad V.T., 2013, AM J ANAL CHEM, V4, P323, DOI [10.4236/ajac.2013.46041, DOI 10.4236/AJAC.2013.46041, 10.4236/ajac.2015.66052, DOI 10.4236/AJAC.2015.66052]
[25]
Miller J. N., 2010, STAT CHEMOMETRICS AN, V6th
[26]
A morpholine-free process amenable convergent synthesis of apixaban: a potent factor Xa inhibitor
[J].
MONATSHEFTE FUR CHEMIE,
2017, 148 (08)
:1477-1482
[28]
1-[3-aminobenzisoxazol-5′-yl]-3-trifluoromethyl-6-12′-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1′]-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-13,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa 10.1016/j.bmel.2006.02.069
[J].
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,
2006, 16 (15)
:4141-4147
[29]
Validation for chromatographic and electrophoretic methods
[J].
QUIMICA NOVA,
2004, 27 (05)
:771-780
[30]
Roy Jiben, 2002, AAPS PharmSciTech, V3, pE6